Human monocytes and macrophages bind Bordetella pertussis through multiple specific receptorligand interactions; however, the effect of these interactions on monocyte and macrophage function is not well understood. In an in vitro system, B. pertussis infection of human monocytes significantly impaired T cell proliferation to exogenous antigen at MOIs as low as 1.0. B. pertussis isogenic mutant strains deficient in filamentous hemagglutinin or adenylate cyclase toxin were incapable of proliferation inhibition, suggesting that these virulence-associated factors are essential for this activity. B. pertussis -induced monocyte death alone did not explain these results, nor did differences in intracellular survival. In addition, B. pertussis infection did not significantly alter monocyte phagocytosis of complement-opsonized latex particles, indicating that B. pertussis infection does not globally impair monocyte functions in this system. These results suggest that B. pertussis may be capable of subverting cellular immune defenses in an infected host.
Bordetella pertussis is the causative agent of whooping interaction between B. pertussis and mononuclear leukocytes could account for the persistence of disease symptoms, and cough, a respiratory disease that affects millions of children throughout the world each year. Many B. pertussis virulenceperhaps of bacteria, in the absence of positive nasopharyngeal swab cultures [3, 14] . This hypothesis would be consistent associated factors have been identified and characterized, including filamentous hemagglutinin (FHA), pertussis toxin (PT), with the finding that B. pertussis DNA persists in the lungs of experimentally infected mice for several weeks to months after adenylate cyclase toxin (AC), pertactin, tracheal cytotoxin, and fimbriae [1 -3] . Most of these factors are regulated by a twoinfection [18 -21] and with the crucial role of an intact cellular immune response in clearing B. pertussis from the murine lung component sensory transduction system that is encoded by the bvgAS operon and that responds to environmental stimuli [4 -[22, 23] . 7]. bvg-null mutants are avirulent in the infant mouse model Efforts to characterize the interaction between B. pertussis and are cleared more quickly than are wild type B. pertussis and human monocytes have focused on the mechanisms of B. in adult animal models [8, 9] .
pertussis adherence. Recognition of FHA by the monocyte/ B. pertussis colonizes the respiratory tract by adhering to macrophage complement receptor CR3 is a critical aspect of ciliated epithelial cells; this interaction has been well-studied B. pertussis binding to monocytes [13, 14] . In addition, the in vitro [3, 10 -12] . B. pertussis also adheres to human mono-FHA amino acid sequence Arg-Gly-Asp (RGD, residues 1097 -cytes and macrophages in vitro in an FHA-dependent manner 1099) is recognized by the monocyte receptor complex com- [13 -15] . Several observations suggest that this may take place posed of leukocyte response integrin (LRI, a ? b 3 ), and integrinin vivo as well [14, 16, 17] . It has been proposed that the associated protein (IAP, CD47) [15] . The LRI/IAP complex regulates monocyte chemotaxis, phagocytosis, and oxidative burst [24] , and may be important in host defenses against bacterial infection [25] . Interaction of FHA RGD with LRI/IAP up-regulates CR3-mediated binding of B. pertussis FHA [15] . preinfection levels by day 3 and remain low through at least day 15 [31] . In addition, B. pertussis AC has been shown to Source or inhibit the monocyte oxidative burst in vitro and to cause Strain Genotype/phenotype reference apoptosis of a murine monocyte-derived cell line [32, 33] .
Tracheal cytotoxin reduces neutrophil chemotactic responses,
BP537
Contains frameshift mutation in bvgS [5, 11] independent of its cytotoxic activity for these cells [34] . clearance of B. pertussis by infected hosts [35] . A loss of these FHA sequence RGD (1097-9):
functions might lead to B. pertussis persistence at low numbers
Contains deletion of PT operon (ptxD6 ) [13] in the lung and in respiratory-associated lymphoid tissue. This
BPA2-6
Contains amino acid substitution in CyaA [38] scenario associated functions by studying the ability of B. pertussisexposed monocytes to stimulate CD4 T cell proliferation to Table 2 . Primers used to construct fhaB deletion mutation tetanus toxoid (TT).
(fhaBD3586).
Name
Primer sequence (5 to 3)
Materials and Methods
Bacterial strains and culture conditions. All bacterial strains 0470FH GCGAAGCTTCAGGCAGCGGCGGGCGAA 261RB GCGGATCCGTGTTCATATTCCGACCAG used are described in CD4 T cell purification. CD4 T cells were purified from monoGengou agar. In each experiment, each strain was analyzed in at least triplicate; the experiments were repeated four times using 3 nuclear cells by use of beads (Dynabeads and Detachabead; Dynal, Lake Success, NY) as described by the manufacturer. These T cell different blood donors. Measurement of monocyte viability. Proliferation assays were populations were not characterized with respect to the relative numbers of cells with Th1 and Th2 phenotypes; however, cells of performed in duplicate with two separate 96-well plates. A preexpanded population of TT-specific CD4 T cells (10 5 ) was cultured both types are presumed to be present. Purified CD4 T cells were resuspended in RPMI / 10% human plasma (HP, derived from in the presence of uninfected or B. pertussis -infected monocytes (3 1 10 4 for FACS analysis, 1 1 10 4 for proliferation assays). At the same donor) and kept on ice until needed.
Preexpansion of TT-specific T cell population. Preexpansion 18 h following infection, one plate was used to measure monocyte viability (in the absence of exposure to TT). Medium was gently of TT-specific T cells was done with a modification of the method described by Nutman [41] . Purified mononuclear cells were resusremoved from each well, replaced with PBS (30 mL) containing 1 mL of anti-CD14 antibody conjugated to FITC (Coulter) and 10 pended in RPMI / 10% HP (from the autologous donor) supplemented with standard amounts of penicillin, streptomycin, glucose, ng/mL propidium iodide (Sigma), and incubated for 30 min at 4ЊC. Plates were then centrifuged for 5 min at 400 g, the supernatant was and L-glutamine; added to 24-well tissue culture plates (1.75 1 10 6 cells/mL, 2 mL/well) in the presence of 3.8 lf/mL TT; and removed from each well, and wells were washed with 200 mL of PBS. Plates were then recentrifuged, the supernatant was removed, cultured for 2 days. Purified IL-2 (20 U/mL) (Life Technologies GIBCO BRL, Gaithersburg, MD) was then added and the cells and the cells were incubated with 100 mL of PBS / 2.5 mM EDTA for 15 min on ice. The cells were then removed from the allowed to incubate 4 additional days. Nonadherent cells were then well bottom by gently pipetting and scraping with a pipette tip removed, split into 2 wells (1 mL/well on a 24-well plate), given and placed on ice. Cell staining was analyzed on a FACScan 1 mL of fresh medium and IL-2 (20 U/mL), and incubated for an (Becton Dickinson). Results are means of four independent experiadditional 4 days. At that time, cells were again provided 1 mL ments, each with a different blood donor. of fresh medium (first removing 1 mL of old medium) and IL-2
Measurement of the ability of monocytes to ingest complement-(20 U/mL), incubated for 4 more days, and harvested for CD4 T opsonized latex beads. Wells were prepared as for proliferation cell purification. assays except that 3 1 10 4 monocytes/well were used and no TT Proliferation assay. Bacteria were suspended in RPMI / 5% was added. At 18 h after infection, medium was gently removed FCS and added to purified monocytes at an MOI of 5 unless from each well, and FITC-conjugated latex beads (Polysciences, otherwise noted. In some cases, bacteria were first heat-killed (30 Warrington, PA) preopsonized with 50% C5-deficient serum min, 55ЊC) or complement-opsonized in 50% C5-deficient serum (Sigma) in RPMI (30 mL, 37ЊC, 15 min) were added, at a 200:1 (15 min, 37ЊC) (Sigma, St. Louis). The bacteria-monocyte mixture ratio of beads to monocytes. Plates were then incubated for 1 h at was incubated in polypropylene tubes for 1 h at 37ЊC on a rotating 37ЊC and centrifuged for 5 min at 400 g, the supernatant was wheel (preblocked with RPMI / 5% FCS to decrease monocyte removed from each well, and wells were incubated with PBS adherence). As a control, uninfected monocytes were also incu-(30 mL) containing 1 mL of anti-CD14 antibody conjugated to bated in this manner. Nonadherent bacteria were removed by washphycoerythrin (Coulter). Plates were incubated for 30 min at 37ЊC, ing twice with RPMI / 5% FCS after low-speed centrifugation and cells were washed and analyzed as described for the measure-(140 g). Monocytes were then resuspended in RPMI / 10% HP ment of monocyte viability. at a concentration of 10 5 cells/mL (after recounting in the presence Data analysis and statistical methods. To calculate the level of trypan blue). Previous experiments have shown that exposure of proliferation in each sample, proliferation values measured in of B. pertussis to non-heat-inactivated 10% HP for 1 h results in wells without TT were subtracted from those measured in wells a ú1000 times decrease in viable bacterial counts [15] . For each with TT. Because of donor-to-donor variability, it was more meansample, monocytes (10 4 /well) were added to CD4 T cells (10 5 / ingful to compare ratios of proliferation for experimental and conwell) in a 96-well plate in the presence or absence of TT (4.5 lf/ trol samples within an experiment. These ratios were consistent mL). These cell mixtures were incubated for 2 days unless otheramong different experiments and different donors. For example, wise noted, pulsed for 20 h with 1 mCi of [ 3 H]thymidine, and proliferation stimulated by BP536-and BP537-infected monocytes harvested on a Combi-cell harvester (Skatron, Sterling, VA). Levmight be 5000 and 20,000 cpm, respectively, for one donor and els of cell-associated tritium per well were determined by use of 2000 and 8000 cpm, respectively, for a second donor; however, a scintillation counter (LS1701; Beckman Instruments, Fullerton, the ratio of proliferation between the BP536-and BP537-infected CA). All samples were analyzed in triplicate and experiments were samples is similar. Therefore, for most experiments, proliferation repeated at least three times (with a different donor for each experivalues for each experimental sample were calculated as a percentment).
age of the mean proliferation in a reference sample (e.g., the prolif-B. pertussis survival within monocytes. Bacteria and monoeration induced by BP537-infected monocytes in the above examcytes were prepared and mixed together as above, at an MOI of ple). Statistical significance for differences between samples was 5 and 30, with a total of 2 1 10 5 monocytes per infection. After calculated by use of Student's two-tailed t test (for paired samples). incubation for 1 h in a rotating wheel, nonadherent bacteria were removed and monocytes were then resuspended in RPMI / 10% We found that this background was greatly reduced when TTwere significantly impaired in their T cell -stimulating capacity after incubation with B. pertussis at a ratio of as low as 1:1 prestimulated CD4 T cells were substituted for fresh CD4 T cells. Since our goal was to determine the ability of B. pertus-(34.3% of levels with uninfected monocytes; P õ .01) ( figure  2) . At an MOI of 10, monocytes were unable to stimulate sis -exposed monocytes to stimulate T cell proliferation in response to a specific antigen (TT), we used a population of CD4 any T cell proliferation above baseline levels. All subsequent experiments were performed using an MOI of 5. (In this experi-T cells prestimulated with TT in vitro for the proliferation assays presented below. This approach has been previously ment, negative numbers reflect proliferation levels in wells containing TT that were less than those in wells without TT.) described [26, 29] .
Kinetics of the T cell response. To determine the optimum No B. pertussis were detected by plate culture methods in culture medium taken from infected monocyte samples after time point at which to measure CD4 T cell proliferation, wells containing monocytes and T cells were incubated for different washing and addition of 10% HP. Efforts to cultivate bacteria from culture medium were negative at time points prior to the time periods before pulsing with )-infected monocytes (MOI Å 30) was significantly less than that of T monocytes were much less able to stimulate antigen-dependent cells cultured in the presence of uninfected monocytes, but the T cell proliferation than were BP537 (Vir 0 )-infected monocytes difference was greatest at day 2 (P õ .05 for all days; P õ (33.8% of levels with BP537; P õ .02) (figure 3), suggesting .02 for day 2); therefore, in all subsequent assays cells were that one or more Bvg-regulated proteins are important in medipulsed with [ 3 H]thymidine at day 2. It should also be noted ating this effect. Interestingly, monocytes exposed to BP537 that the proliferation of B. pertussis -infected monocytes and were still significantly less able to stimulate T cell proliferation uninfected monocytes in the absence of TT remained constant to TT than were unexposed monocytes (100% vs. 202%; P õ over the time course and was significantly less than that of T .05), suggesting that non -Bvg-regulated factors may also play cells cultured with uninfected monocytes in the presence of a role in impairing monocyte function. Heat killing of BP536 TT.
reduced its ability to inhibit monocyte function to about that Increasing the MOI of BP536 decreases the ability of monoof BP537 (95.7% of BP537 levels), suggesting that at least one cytes to stimulate T cell proliferation to TT. Purified monoof the factors involved in impairing monocyte function is either heat-sensitive or that this activity requires active participation of B. pertussis. Opsonization of BP536 with complement also reduced its ability to inhibit monocyte function, although not quite to the degree of heat killing (70.5% of BP537). This result suggests that complement deposition blocks the function of at least one of the involved Bvg-regulated proteins or that complement deposition alters the B. pertussis -monocyte interaction in some other fashion (e.g., alters bacterial binding, entry, or survival).
AC and FHA play a role in B. pertussis inhibition of monocyte-dependent T cell proliferation.
Since some Bvg-regulated factors were important in inhibiting monocyte function, we tested isogenic mutants deficient in specific Bvg-regulated factors for their ability to inhibit monocyte-dependent T cell proliferation (figure 4). Mutants lacking either the hemolytic (BP32-5) or the catalytic (BPA2-6) domain of AC (CyaA) were unable to inhibit this monocyte function (103% of BP537 levels, P õ .8, and 115% of BP537 levels, P õ .38). In addition, Thus, under these conditions, very few if any viable bacteria remained in monocytes at the time point used for measurement of T cell proliferative responses. Furthermore, in the T cell proliferation experiments described above, only 10 4 monocytes were incubated with bacteria per well, using MOIs between 1 and 30; hence, it is unlikely that any viable bacteria were present. In any case, the impaired inhibitory ability of BP3586, BP32-5, and BPA2-6 could not be explained by decreased numbers of intracellular bacteria relative to the wild type.
Monocyte cell death does not fully account for the decrease in the T cell proliferative response with BP536-infected monocytes. Cells were removed from proliferation assay wells after 18 h of infection with B. pertussis, stained with anti-CD14 antibody (to identify monocytes) and propidium iodide (to identify dead cells), and analyzed by FACS. There was a 40% reduction in viable monocytes in wells after incubation with BP536 relative to the numbers found after incubation with 23.5% of BP537 levels, P õ .02; BP536, 14.7% of BP537 levels, P õ .01). Finally, a mutant deficient in PT expression (BPTOX-6) was able to inhibit this monocyte function almost as well as did the parental strain (BPTOX-6, 19.5% of BP537 levels, P õ .05; BP536, 14.2% of BP537 levels, P õ .02). As a comparison, we also tested a plasmid-cured strain of Y. pseudotuberculosis. This strain, YP137, exhibits high levels of attachment and entry into a variety of host cells, although it does not express any Yops [42 -46] . Our results indicate that this Y. pseudotuberculosis strain does inhibit monocyte-dependent CD4 T cell proliferation, but to a lesser degree than does BP536 (YP137, 58% of BP537, BP536, 14.2% of BP537; P õ .01).
Inhibitory activity of B. pertussis does not correlate with intracellular survival. We assessed the possibility that inhibition of antigen-dependent T cell proliferation by a particular were infected with either BP536, BP537, BP3586, BP32-5, or cific CD4 T cells (10 5 ) was cultured in presence of unexposed or B. pertussis -exposed monocytes (10 4 ). In some cases, bacteria were BPA2-6, at an MOI of 5 or 30, and then incubated in the either first heat-killed or opsonized in C5-deficient serum. Cultures presence of non -heat-inactivated HP, under the same experiwere pulsed at day 2 with [ to determine the percentage of monocytes having ingested these beads. There was no significant difference in the ability of uninfected monocytes, BPA2-6 -infected monocytes, or BP536-infected monocytes to ingest beads (75.3 / 4.4%, 81.5 / 7.6%, 76 / 7.5% of CD14 cells contained fluorescent beads, respectively; mean channel fluorescence of each population was about equal). This suggests that monocytes exposed to virulent B. pertussis, while deficient in supporting antigen-dependent T cell proliferation, do retain some important cellular functions.
Discussion
The purpose of this study was to determine whether incubation of B. pertussis with monocytes could negatively affect the 
BPA2-6 (AC 0
. A strain deficient in PT expression was also associated with significant levels of monocyte death (Ç50% the number of viable monocytes as that associated with BPA2-6). To compensate for BP536-induced monocyte death in our assessment of T cell proliferative responses, proliferation assays were performed using 50% (5 1 10 3 ) of the usual number (10 4 ) of uninfected or BPA2-6 -infected monocytes. Even under these conditions, there was significantly less proliferation with the BP536-infected monocytes than with half the number of uninfected or BPA2-6 -infected monocytes (proliferative response with 10 4 BP536-infected monocytes was equivalent to fected monocytes), and there was no significant difference in pertussis -infected monocytes. Preexpanded population of tetanus the degree of proliferative response using 5 1 10 3 versus 10 4 toxoid -specific CD4 T cells (10 5 ) was cultured in presence of uninfected or B. pertussis -infected monocytes (10 antigen-presenting function of these cells. We have shown that
The involvement of specific monocyte receptors in the recognition of microbial adhesins may determine in part the subsemonocytes, after incubation with B. pertussis, are not able to stimulate CD4 T cell proliferation to TT to the same degree quent impact of microbial attachment or internalization on monocyte immune effector activities, such as antigen presentaas can unexposed control cells. This B. pertussis inhibitory effect occurred at an MOI as low as 1 bacterium per monocyte.
tion. Pryjma et al. [29] demonstrated that monocytes are less able to stimulate T cell proliferation to TT after ingestion of We have also shown that this effect is dependent on intact FHA and AC but not PT. The death of some B. pertussiscomplement-opsonized bacteria such as E. coli, Salmonella enteritidis, Pseudomonas aeruginosa, and S. aureus. While exposed monocytes does not fully explain T cell proliferation impairment. Our failure to detect viable bacteria in monocyte bacterial ligation by the complement receptor CR3 may lead to some inhibition of antigen-dependent T cell proliferation, culture medium prior to addition of the T cells suggests that few if any organisms were available to act directly on these the exact degree of inhibition may also depend on the specific ligand involved. For example, we noted greater inhibition by cells. In addition, few if any organisms could be recovered from infected monocytes, and there were no significant differences virulent B. pertussis BP536 in the presence of heat-inactivated serum than by the same organism when complement-opsonized between strains in the numbers of surviving bacteria. Thus, we believe that the primary B. pertussis inhibitory effect is exerted ( figure 3) suggests that bacterial attachment and cellular entry are not fully sufficient for inhibition of antigen-dependent monocyte numbers, especially when an MOI of 100 is used [14, 37, 50, 51] . However, the significance of these interactions for B.
stimulation of CD4 T cell proliferation. As mentioned above, possible mechanisms of inhibition inpertussis pathogenesis has not been clearly defined. It has been suggested that B. pertussis may become sequestered from the clude interference with antigen processing or expression of major histocompatibility complex class II antigens, other surimmune response in an intracellular niche, although this hypothesis has not been proven [13, 14, 16] . Another (but not face antigens, or stimulatory cytokines; interference with monocyte costimulatory functions; and enhancement of supmutually exclusive) possibility is that interactions of B. pertussis with professional antigen-presenting cells may render the pressive activities [29] . Gercken et al. [26] demonstrated that monocytes containing opsonized bacteria, such as Mycobactelatter less capable of stimulating a T cell response against B. pertussis. This bacterial effect might simply require host cell rium-infected monocytes, are defective in accessory (costimulatory) cell functions. Mycobacterium-infected monocytes are attachment and subsequent delivery of immunomodulating toxins. If true, this might be an important mechanism of immune also defective in antigen processing and presentation [26] . These investigators also observed loss of viability in Ç20% -evasion in vivo. Functional deactivation is increasingly recognized as a means by which some intracellular microbes estab-35% of monocytes after bacterial engulfment but provided data suggesting that monocyte death could not account entirely for lish states of chronic infection [52] .
Evidence to support this scenario comes from studies in the decreased antigen-dependent T cell proliferation. Our data implicate AC and FHA in the B. pertussis -associated inhibiwhich a strong Th1 response was associated with B. pertussis clearance from the lungs of experimentally infected mice [22, tion of antigen-dependent T cell proliferation. Monocyte death only partly explains the decreased ability of B. pertussis -in-23, 53]. Thus, a decreased T cell response at the onset of infection might enhance pulmonary colonization and allow B.
fected monocytes to stimulate CD4 T cell proliferation to TT. When the number of uninfected or BPA2-6 -infected monopertussis to remain in the lungs for longer periods of time. Interestingly, AC-defective mutants, which were unable to incytes incubated with CD4 T cells was reduced so that the number would be similar to the remaining number of viable hibit monocyte function in our study, are also unable to colonize the lung in the adult mouse model and are avirulent in BP536-infected monocytes (5 1 10   3 ), the amount of proliferation in these wells was still significantly greater than that in the infant mouse model [8, 9, 54] . M. tuberculosis, another pathogen that depends on a strong Th1 response for clearance wells containing 10 4 BP536-infected monocytes. In addition, there was no difference in the percentage of BP536-infected, from the lung, also inhibits monocyte antigen-presenting cell function, in this case by disrupting accessory and antigen-pre-BPA2-6 -infected, and uninfected CD14-positive cells that were able to ingest opsonized latex beads, suggesting that viasenting cell functions [26 -28] .
